207,831 cases of leprosy were reported in Brazil, of which 4,069 in PB. Male patients predominated (51.38%, 56.57%) in PB and Brazil, respectively; as well as brown color (54.67%, 51.58%); and incomplete elementary school (44.11%, 49.13%). The dimorphic form was the most prevalent condition (PB: 25%, Brazil: 36%), with the majority of the patients diagnosed with multibacillary leprosy (PB: 52.93%, Brazil: 62.04%). Polychemotherapy with 12 doses was the preferred therapy (52.29%, 61.53%). The highest incidences occurred in 2009, 23.28 cases / 100,000 inhabitants, in PB, and in 2008, in Brazil: 24.35 cases / 100,000 inhabitants. Also, in 2008, there was identified a higher incidence in children under 15 years of age in both locations. Conclusion: A similar clinicalepidemiological profile was found for both localities, with a reduction in the incidence of leprosy in the studied period. However, endemicity remains high and indicates the need for a strengthening of epidemiological control actions to fight this disease. Studies such as ours, which outline the clinical and epidemiological profile of the patients, allow for a more accurate reality-driven planning of strategies. DESCRIPTORS Leprosy. Epidemiology. Health Profile.http://periodicos.ufpb.br/ojs2/index.php/rbcs
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2025 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.